Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials - Wikidata - awgldk - TriplyDB

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

http://www.wikidata.org/entity/Q26824909

about

Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors.TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression.Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.The role of APE/Ref-1 signaling pathway in hepatocellular carcinoma progression.An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma.Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma.Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.Investigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatment.Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma.De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas

P2860

Q26772315-9B453FA8-F484-48BB-A3D6-E01A8A2E6B12 Q26799048-735649E5-AB04-4A9A-994B-37A471B23242 Q26823523-43E0B28E-DC7C-44FD-8FA5-AFA1D10E42FC Q26999411-F297487C-D4F5-4DF0-824E-8D740A5A99B1 Q33914111-551DA204-437F-4E02-9034-385F1C30EF01 Q34077177-3BA218AB-52D8-4546-B5E9-415081F6D31F Q34105182-1B6410A7-2298-41E7-88EB-CB7BEBDD1731 Q34130156-C94C8CAB-ED6B-4D81-A18F-DD7DACC78215 Q35790450-0FFB58D9-3AB7-45E8-875A-434612004FDD Q36185043-FBF65A75-B04F-4C4D-8600-360A8F816D99 Q36225840-E89977EE-8740-4C3D-A102-F3EC31CD3715 Q36528077-58DF0815-5F80-4BE3-BA0C-3C89EB94C5A7 Q37096235-C12C496F-CC9E-4EB0-9044-5E0BDDEF59FC Q37288407-A2F19469-B809-4AD9-BF69-CD593F789DFD Q37407115-C6EF36FB-D7A1-477D-9A52-6386A56C615B Q38588428-F6B174D5-9BF5-43A5-87C9-7739F9AFA49D Q38635603-F5620571-407B-4013-A3AE-F3C5BCE576C8 Q38708855-0DF711F6-18BA-48B1-92E8-B6401E7E0A31 Q38713376-DBD91B6D-DC11-414C-9D5A-96EE8E366019 Q38743109-2CE3317E-EA78-40A3-9937-17DBA2AF199F Q38777365-DAEF1D0C-081C-41AB-96A6-9E7D75FF34F8 Q38952531-AD58BD1D-1487-4E8C-81C7-7030A4EB739E Q38985971-9250C973-3A31-4550-84CE-BCFDA27718CD Q40316507-12471A79-5C9F-4238-A5F9-87A933D5531C Q41539096-A9E76C3F-0811-48FF-9862-9558B06A6582 Q41791058-00A46098-6191-4E72-AB19-E2A8DE2BB72E Q42292467-B995DB84-314B-4273-9A25-843C02B85EFB Q42434482-D09F2721-9C9E-4831-BB57-B0BA98DF3DB9 Q47129854-98300E7A-76B0-4624-B2F1-80989EEBFB2D Q47138001-0D39F55C-DF2A-43EC-B80E-C45C9F6C5641 Q49542602-DF1F2ACA-E7C4-45F6-826B-55B9C37AF27B Q57174326-55FDC034-5985-4438-B92F-BE996E528B3A

P2860

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

http://www.wikidata.org/entity/Q26824909

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@ast

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@en

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@nl

type

label

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@ast

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@en

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@nl

prefLabel

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@ast

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@en

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@nl

P1433

Q26824909-A5244484-B361-41F4-9A7B-BD97BE0C7A0A

P1476

Q26824909-D44EA801-0FCB-4519-BB38-DC1771EDD24C

P2093

Q26824909-1511086D-4CAC-4551-BA56-5B114727B2F4

Q26824909-3CF7BB76-8EA7-4E85-9247-E0E30D5B524F

Q26824909-4439A688-6D57-4A41-B9EE-6FEDA5E53709

Q26824909-50478B20-1E2E-47F7-ABB4-DD5318572664

Q26824909-99567CFE-16BA-4D4C-B4E1-D388FF4EE8CE

Q26824909-A23F259F-A61C-4649-A68D-1A585A0C9F0D

Q26824909-FD3ED759-05E6-47F8-A761-2392A48A4C42

P2860

Q26824909-059FBDE7-4CB6-4EE9-9707-24509D723A58

Q26824909-05CC930C-F2DA-4567-A4BD-7F3D6CF5FB26

Q26824909-0634CC54-58C8-4CF6-998B-DC6C7B40DDCE

Q26824909-0636BF18-3C10-4F71-A5B9-37461E9D66FC

Q26824909-096429D2-6F06-4E72-8207-E903E6321B9F

Q26824909-0BD5DDDE-E4B8-4018-9AF4-B3070DE0D14E

Q26824909-0C607A66-BC01-407D-BA65-65387A3B08F4

Q26824909-0D942278-6394-482F-99BC-BEEB4FBEB6A4

Q26824909-11B165F9-FA81-482F-8020-D9A9A58E6253

Q26824909-165869D9-A449-46F6-B7B1-8019D500BF57

P304

Q26824909-EA876258-6149-432F-A23F-08372914761A

P31

Q26824909-C0C00627-2218-4ADF-8F52-9E332E2DA010

P3181

Q26824909-FC2D8D05-5721-4313-8AD4-5449D9520808

P356

Q26824909-8EC08A9E-5BA4-4D39-9FE6-EA99D0752A71

P407

Q26824909-ADF8EFAF-FBC0-4F02-9A40-D090DAB09C36

P433

Q26824909-699463A3-67A0-4323-91F9-6D502A3BC41C

P478

Q26824909-20E07639-4458-4580-B731-D2ABF4E3E07B

P50

Q26824909-E576D5D3-2D24-4DD9-A81C-1CA7989702D3

P577

Q26824909-833C068B-ED36-4AE5-8F66-09C31F8842F8

P5875

Q26824909-51EF64F5-1CEE-4867-A97D-DEA996D663A4

P698

Q26824909-C0D2CD74-26AC-47D6-B6DD-45DBD366E760

P932

Q26824909-B8B952F5-815D-40E1-8512-1D729A7A2DB9

P3181

P356

WJG.V20.I5.1268

P1433

World Journal of Gastroenterology

P1476

Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

@en

P2093

Barbara Dapas

http://www.w3.org/2001/XMLSchema#string

Bruna Scaggiante

http://www.w3.org/2001/XMLSchema#string

Gabriele Grassi

http://www.w3.org/2001/XMLSchema#string

Gabriele Pozzato

http://www.w3.org/2001/XMLSchema#string

Mario Grassi

http://www.w3.org/2001/XMLSchema#string

Maryam Kazemi

http://www.w3.org/2001/XMLSchema#string

Rosella Farra

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Hallmarks of Cancer: The Next Generation

The centriolar satellite protein SSX2IP promotes centrosome maturation

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma

DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.

Argonaute2 is the catalytic engine of mammalian RNAi

Oncomirs - microRNAs with a role in cancer

Wnt signaling and cancer

P304

1268-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4195301

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V20.I5.1268

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizio Zanconati

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260397020

http://www.w3.org/2001/XMLSchema#string

P698

24574801

http://www.w3.org/2001/XMLSchema#string

P932

3921509

http://www.w3.org/2001/XMLSchema#string